SCHEMBL141554

SCHEMBL141554

CC(=O)C=CC=Cc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.73
TDP1 Q9NUW8 1/20 0.73
HDAC3 O15379 3/20 0.63
HDAC4 P56524 3/20 0.63
HDAC1 Q13547 3/20 0.63
HDAC2 Q92769 3/20 0.63
HDAC8 Q9BY41 3/20 0.63
HDAC6 Q9UBN7 3/20 0.63
HDAC7 Q8WUI4 2/20 0.63
HDAC10 Q969S8 2/20 0.63
HDAC11 Q96DB2 2/20 0.63
HDAC9 Q9UKV0 2/20 0.63
HDAC5 Q9UQL6 2/20 0.63
MAOB P27338 9/20 0.58
MAPT P10636 4/20 0.54
LMNA P02545 4/20 0.54
ALDH1A1 P00352 3/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2D6 P10635 2/20 0.54
PLIN1 O60240 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529691 1.00 GLA (0.73) GLATDP1HDAC3HDAC4HDAC1
SCHEMBL10911551 1.00 GLA (0.73) GLATDP1HDAC3HDAC4HDAC1
SCHEMBL1105479 1.00 GLA (0.73) GLATDP1HDAC3HDAC4HDAC1
Acetone SCHEMBL11002206 0.98 GLA (0.70) GLATDP1HDAC3HDAC4HDAC1
SCHEMBL1374180 0.98 GLA (0.70) GLATDP1HDAC3HDAC4HDAC1
SCHEMBL735374 0.98 GLA (0.70) GLATDP1HDAC3HDAC4HDAC1
SCHEMBL31349694 0.98 GLA (0.70) GLATDP1HDAC3HDAC4HDAC1
Juarezic Acid SCHEMBL28980693 0.86 HDAC3 (0.63) GLATDP1HDAC3HDAC4HDAC1
SCHEMBL15163748 0.86 HDAC3 (0.61) GLATDP1HDAC3HDAC4HDAC1
Butenone SCHEMBL12984182 0.85 TDP1 (1.00) GLATDP1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1088 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229639-A1 METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE GBS Global Biopharma, Inc. (CA) 2023-08-23 EP claimed
WO-2022081889-A1 METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE GBS GLOBAL BIOPHARMA, INC. (CA) 2022-04-21 WO claimed
US-20080221106-A1 Arylamine Ketones, Their Preparation Methods, The Pharmaceutical Composition Containing Them And Their Use INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2008-09-11 US claimed
CN-101146772-A Arylamine ketone compound, synthesis method thereof, pharmaceutical composition containing arylamine ketone compound and application of arylamine ketone compound INST MATERIA MEDICA CAMS (CN) 2008-03-19 CN claimed
EP-1783115-A1 ARYLAMINE KETONES, THEIR PREPARATION METHODS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2007-05-09 EP claimed
US-6562538-B2 Developing electrostatic latent image formed on image bearing member with a color developer including color toner to form a color toner image; transferring color toner image onto endless intermediate transfer material; biasing; repeating RICOH COMPANY, LTD (JP) 2003-05-13 US claimed
US-5814427-A RESIN BINDER, FOR REUSE OF WASTE PAPER BANDO CHEMICAL INDUSTRIES, LTD. (JP) 1998-09-29 US claimed
US-4514267-A Zinc electroplating additive concentrate OMI INTERNATIONAL CORPORATION (US) 1985-04-30 US claimed
EP-3952651-B1 USE OF BENZOXEPINE DERIVATIVES AS HERBICIDES ECOLE POLYTECH (FR) 2025-04-23 EP disclosed
CN-119528983-A Method for green catalytic synthesis of gamma-ketophosphine oxide by asymmetric alkylaluminum compound 北京理工大学 2025-02-28 CN disclosed
US-20240241458-A1 TONER, DEVELOPING AGENT, TONER ACCOMMODATING UNIT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2024-07-18 US disclosed
CN-118050964-A Carrier, developer, method and apparatus for electrophotographic image formation 株式会社理光 2024-05-17 CN disclosed
US-11934146-B2 Toner and method for producing toner CANON KABUSHIKI KAISHA (JP) 2024-03-19 US disclosed
US-11934147-B2 Toner CANON KABUSHIKI KAISHA (JP) 2024-03-19 US disclosed
US-4568625-A SILICONE HAVING AMINE ON SIDE CHAIN THEREOF CANON KABUSHIKI KAISHA (JP) 1986-02-04 US disclosed
US-4565763-A MELT BLENDING, PULVERIZATION CANON KABUSHIKI KAISHA (JP) 1986-01-21 US disclosed
US-4514267-A Zinc electroplating additive concentrate OMI INTERNATIONAL CORPORATION (US) 1985-04-30 US disclosed
US-4448870-A Magnetic color toner CANON KABUSHIKI KAISHA (JP) 1984-05-15 US disclosed
US-4433040-A Electrophotographic toner containing a metal complex dye HODOGAYA CHEMICAL COMPANY, LTD. (JP) 1984-02-21 US disclosed
EP-0059814-A1 Electrophotographic toner HODOGAYA CHEMICAL CO., LTD. (JP) 1982-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221106-A1 Arylamine Ketones, Their Preparation Methods, The Pharmaceutical Composition Containing Them And Their Use AHR, KYNU, AADAC GLA 540/4885TDP1 2946/4885HDAC3 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.